Is RHNMF or DIVO a better dividend investment in 2026?

RHNMF currently yields 10526.32% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: RHNMF offers higher current income.

What is the dividend yield difference between RHNMF and DIVO?

RHNMF has a forward dividend yield of 10526.32% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 10519.83 percentage points.

Home › Compare › RHNMF vs DIVO

RHNMF vs DIVO: Dividend Comparison 2026

RHNMF yields 10526.32% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RHNMF wins by $91421458538285344.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RHNMF

● Live price

10526.32%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$91421458538285344.00M

Annual income

$89,744,322,218,307,970,000,000.00

Full RHNMF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — RHNMF vs DIVO

📍 RHNMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RHNMF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RHNMF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RHNMF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHNMF

Annual income on $10K today (after 15% tax)

$894,736.84/yr

After 10yr DRIP, annual income (after tax)

$76,282,673,885,561,770,000,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, RHNMF beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHNMF + DIVO for your $10,000?

RHNMF: 50%DIVO: 50%

100% DIVO50/50100% RHNMF

Portfolio after 10yr

$45710729269142672.00M

Annual income

$44,872,161,109,153,986,000,000.00/yr

Blended yield

98.17%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHNMF buys

DIVO buys

No recent congressional trades found for RHNMF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRHNMFDIVO

Forward yield	10526.32% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$91421458538285344.00M ✓	$30.7K
Annual income after 10y	$89,744,322,218,307,970,000,000.00 ✓	$981.68
Total dividends collected	$91309952364754128.00M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RHNMF vs DIVO ($10,000, DRIP)

Year	RHNMF Portfolio	RHNMF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$1,063,332	$1,052,631.58	$11,349	$649.42	+$1.05M → RHNMF
2	$105,744,905	$104,607,140.08	$12,833	$688.83	+$105.73M → RHNMF
3	$9,835,430,757	$9,722,283,708.79	$14,459	$727.90	+$9835.42M → RHNMF
4	$855,644,041,989	$845,120,131,078.84	$16,238	$766.49	+$855644.03M → RHNMF
5	$69,627,827,846,009	$68,712,288,721,080.95	$18,179	$804.47	+$69627827.83M → RHNMF
6	$5,300,152,192,813,391	$5,225,650,417,018,161.00	$20,293	$841.71	+$5300152192.79M → RHNMF
7	$377,430,657,448,967,200	$371,759,494,602,656,830.00	$22,591	$878.14	+$377430657448.94M → RHNMF
8	$25,145,413,383,015,215,000	$24,741,562,579,544,820,000.00	$25,087	$913.65	+$25145413383015.19M → RHNMF
9	$1,567,417,121,474,185,500,000	$1,540,511,529,154,359,300,000.00	$27,791	$948.18	+$1567417121474185.50M → RHNMF
10	$91,421,458,538,285,340,000,000	$89,744,322,218,307,970,000,000.00	$30,718	$981.68	+$91421458538285344.00M → RHNMF

RHNMF vs DIVO: Complete Analysis 2026

RHNMF — Stock

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.

Full RHNMF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RHNMF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHNMF vs SCHD RHNMF vs JEPI RHNMF vs O RHNMF vs KO RHNMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.